We are live on ! Find out more
IHE icon

iShares US Pharmaceuticals ETF
IHE

82 hedge funds and large institutions have $147M invested in iShares US Pharmaceuticals ETF in 2019 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 17 increasing their positions, 34 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

37.62% more ownership

Funds ownership: 102.5% → 140.12% (+38%)

33% more capital invested

Capital invested by funds: $111M → $147M (+$36.3M)

6% less funds holding

Funds holding: 87 → 82 (-5)

31% less first-time investments, than exits

New positions opened: 9 | Existing positions closed: 13

50% less repeat investments, than reductions

Existing positions increased: 17 | Existing positions reduced: 34

100% less call options, than puts

Call options by funds: $1K | Put options by funds: $348K

Holders
82
Holders Change
-5
Holders Change %
-5.75%
% of All Funds
1.8%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
17
Reduced
34
Closed
13
Calls
$1K
Puts
$348K
Net Calls
-$347K
Net Calls Change
-$349K

Top Buyers

Rank Fund Capital Flow
1
Goldman Sachs
Goldman Sachs
New York
+$57.5M
2
RCYC
Richard C. Young & Co
Rhode Island
+$3.92M
3
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
+$3.47M
4
Fisher Asset Management
Fisher Asset Management
Washington
+$222K
5
Wolverine Trading
Wolverine Trading
Illinois
+$221K

Top Sellers

Rank Fund Capital Flow
1
Jane Street
Jane Street
New York
-$6.2M
2
BW
Biegel & Waller
Maryland
-$5.99M
3
Morgan Stanley
Morgan Stanley
New York
-$1.61M
4
Wells Fargo
Wells Fargo
California
-$1.05M
5
TRCT
Tower Research Capital (TRC)
New York
-$1.01M
Name Holding Trade Value Shares
Change 		Change in
Stake
HGWM
76
Harvest Group Wealth Management
Massachusetts
$11K +$11.5K +240 New
NFG
77
Next Financial Group
Texas
$8K -$21.7K -453 -73%
AA
78
AlphaMark Advisors
Kentucky
$7K – – –
S
79
SignatureFD
Georgia
$7K – – –
BCWM
80
Bartlett & Co Wealth Management
Ohio
$4.2K – – –
BC
81
Bartlett & Co
Ohio
$4K – – –
PA
82
Parallel Advisors
California
$4K +$3.73K +78 New
BW
83
Biegel & Waller
Maryland
– -$5.99M -119,148 Closed
AWA
84
ARS Wealth Advisors
Florida
– -$349K -6,933 Closed
AFC
85
AFT Forsyth & Company
Florida
– -$217K -4,314 Closed
NFC
86
Northeast Financial Consultants
Connecticut
– -$208K -4,140 Closed
Mariner
87
Mariner
Kansas
– -$205K -4,068 Closed
PAG
88
Private Advisor Group
New Jersey
– -$202K -4,020 Closed
ESB
89
Essex Savings Bank
Connecticut
– -$166K -3,300 Closed
MWM
90
Meridian Wealth Management
Kentucky
– -$910 -1,812 Closed
BWM
91
BerganKDV Wealth Management
Minnesota
– -$20K -393 Closed
DSC
92
Duncker Streett & Co
Missouri
– -$15K -300 Closed
TPWA
93
TRUE Private Wealth Advisors
Oregon
– -$6K -120 Closed
TFA
94
Transamerica Financial Advisors
Florida
– -$1K -12 Closed
1 2 3
4

IHE Hedge Fund Activity: Q3 2019 in Review

82 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in iShares US Pharmaceuticals ETF (IHE) for Q3 2019, worth a combined $147M — up 33% from $111M a quarter earlier.

Sellers outnumbered buyers: 13 funds closed out of IHE and 9 opened new positions — a net loss of 4 holders — while 34 trimmed existing stakes and 17 added.

The largest buyer was Goldman Sachs, adding an estimated $57.5M. The largest seller was Jane Street, cutting an estimated $6.2M.

  • 82 institutional investors held iShares US Pharmaceuticals ETF (IHE) as of Q3 2019, down from 87 in Q2 2019.
  • Funds reported $147M of iShares US Pharmaceuticals ETF stock for Q3 2019, up 33% quarter-over-quarter.
  • 9 funds opened new iShares US Pharmaceuticals ETF positions in Q3 2019 and 13 closed out, a net change of -4 holders.
  • The largest iShares US Pharmaceuticals ETF buyer in Q3 2019 was Goldman Sachs, an estimated $57.5M added.
  • The largest iShares US Pharmaceuticals ETF seller in Q3 2019 was Jane Street, an estimated $6.2M sold.

Based on aggregated 13F filings for Q3 2019.